Completed OBSERVATIONAL NCT04787510

COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

Sponsor: INTERNAL MEDICINE DEPARTMENT, 1ST WARD

Conditions COVID-19 Disease Hospitalized Patients SARS-COV2 Infection

Interventions low molecular weight Heparin as standard of care treatment

Updated 6 times since 2021 Last updated: Sep 27, 2021 Started: Dec 23, 2020 Primary completion: May 23, 2021 Completion: Jun 23, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04787510, this observational or N/A phase trial focuses on COVID-19 Disease and Hospitalized Patients and remains completed. Sponsored by INTERNAL MEDICINE DEPARTMENT, 1ST WARD, it has been updated 6 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Oct 2021 — Dec 2021 [monthly]

Completed

Status: Recruiting → Completed

▶ Show 1 earlier version

Apr 2021 — Oct 2021 [monthly]

Recruiting

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

INTERNAL MEDICINE DEPARTMENT, 1ST WARD
University Hospital, Ioannina

Data source: University Hospital, Ioannina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ioannina, Greece